Arylazide photoaffinity probe for α2-adrenoceptors

John W Regan, Robert M. DeMarinis, Robert J. Lefkowitz

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

An arylazide photoaffinity probe for α2-adrenoceptors has been developed and characterized. The compound, 3-methyl-6-chloro-9-azido-1H-2,3,4,5-tetrahydro-3-benzazepine (SKF 102229), had a Ki for the human platelet α2-adrenoceptor of ~40 nM. Upon exposure to ultraviolet light, SKF 102229 irreversibly blocked the binding of [3H]yohimbine to both membrane bound and solubilized, partially purified, receptors. The extent of α2-adrenoceptor blockade was dependent upon both the length of exposure to ultraviolet light and the concentration of SKF 102229. Typically, a 60% decrease in α2-adrenoceptor number is obtained following 8 min of photolysis in the presence of 100 nM SKF 102229. The pharmacologic characteristics of the irreversible blockade produced by SKF 102229 were those of an α2-adrenoceptor. Thus, photodependent, irreversible blockade of α2-adrenoceptors by SKF 102229 was prevented by the concomitant presence of phentolamine or p-aminoclonidine but not by prazosin. Given its specificity and efficient blockade of the ligand binding site, SKF 102229 should prove useful for studies of the structure and function of α2-adrenoceptors.

Original languageEnglish (US)
Pages (from-to)3667-3672
Number of pages6
JournalBiochemical Pharmacology
Volume34
Issue number20
DOIs
StatePublished - Oct 15 1985
Externally publishedYes

Fingerprint

Adrenergic Receptors
Ultraviolet Rays
Yohimbine
SK&F 102229
Prazosin
Phentolamine
Photolysis
Platelets
Blood Platelets
Binding Sites
Ligands
Membranes

ASJC Scopus subject areas

  • Pharmacology

Cite this

Arylazide photoaffinity probe for α2-adrenoceptors. / Regan, John W; DeMarinis, Robert M.; Lefkowitz, Robert J.

In: Biochemical Pharmacology, Vol. 34, No. 20, 15.10.1985, p. 3667-3672.

Research output: Contribution to journalArticle

Regan, John W ; DeMarinis, Robert M. ; Lefkowitz, Robert J. / Arylazide photoaffinity probe for α2-adrenoceptors. In: Biochemical Pharmacology. 1985 ; Vol. 34, No. 20. pp. 3667-3672.
@article{a04115771d52427dbb4296593a4f3b26,
title = "Arylazide photoaffinity probe for α2-adrenoceptors",
abstract = "An arylazide photoaffinity probe for α2-adrenoceptors has been developed and characterized. The compound, 3-methyl-6-chloro-9-azido-1H-2,3,4,5-tetrahydro-3-benzazepine (SKF 102229), had a Ki for the human platelet α2-adrenoceptor of ~40 nM. Upon exposure to ultraviolet light, SKF 102229 irreversibly blocked the binding of [3H]yohimbine to both membrane bound and solubilized, partially purified, receptors. The extent of α2-adrenoceptor blockade was dependent upon both the length of exposure to ultraviolet light and the concentration of SKF 102229. Typically, a 60{\%} decrease in α2-adrenoceptor number is obtained following 8 min of photolysis in the presence of 100 nM SKF 102229. The pharmacologic characteristics of the irreversible blockade produced by SKF 102229 were those of an α2-adrenoceptor. Thus, photodependent, irreversible blockade of α2-adrenoceptors by SKF 102229 was prevented by the concomitant presence of phentolamine or p-aminoclonidine but not by prazosin. Given its specificity and efficient blockade of the ligand binding site, SKF 102229 should prove useful for studies of the structure and function of α2-adrenoceptors.",
author = "Regan, {John W} and DeMarinis, {Robert M.} and Lefkowitz, {Robert J.}",
year = "1985",
month = "10",
day = "15",
doi = "10.1016/0006-2952(85)90228-X",
language = "English (US)",
volume = "34",
pages = "3667--3672",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "20",

}

TY - JOUR

T1 - Arylazide photoaffinity probe for α2-adrenoceptors

AU - Regan, John W

AU - DeMarinis, Robert M.

AU - Lefkowitz, Robert J.

PY - 1985/10/15

Y1 - 1985/10/15

N2 - An arylazide photoaffinity probe for α2-adrenoceptors has been developed and characterized. The compound, 3-methyl-6-chloro-9-azido-1H-2,3,4,5-tetrahydro-3-benzazepine (SKF 102229), had a Ki for the human platelet α2-adrenoceptor of ~40 nM. Upon exposure to ultraviolet light, SKF 102229 irreversibly blocked the binding of [3H]yohimbine to both membrane bound and solubilized, partially purified, receptors. The extent of α2-adrenoceptor blockade was dependent upon both the length of exposure to ultraviolet light and the concentration of SKF 102229. Typically, a 60% decrease in α2-adrenoceptor number is obtained following 8 min of photolysis in the presence of 100 nM SKF 102229. The pharmacologic characteristics of the irreversible blockade produced by SKF 102229 were those of an α2-adrenoceptor. Thus, photodependent, irreversible blockade of α2-adrenoceptors by SKF 102229 was prevented by the concomitant presence of phentolamine or p-aminoclonidine but not by prazosin. Given its specificity and efficient blockade of the ligand binding site, SKF 102229 should prove useful for studies of the structure and function of α2-adrenoceptors.

AB - An arylazide photoaffinity probe for α2-adrenoceptors has been developed and characterized. The compound, 3-methyl-6-chloro-9-azido-1H-2,3,4,5-tetrahydro-3-benzazepine (SKF 102229), had a Ki for the human platelet α2-adrenoceptor of ~40 nM. Upon exposure to ultraviolet light, SKF 102229 irreversibly blocked the binding of [3H]yohimbine to both membrane bound and solubilized, partially purified, receptors. The extent of α2-adrenoceptor blockade was dependent upon both the length of exposure to ultraviolet light and the concentration of SKF 102229. Typically, a 60% decrease in α2-adrenoceptor number is obtained following 8 min of photolysis in the presence of 100 nM SKF 102229. The pharmacologic characteristics of the irreversible blockade produced by SKF 102229 were those of an α2-adrenoceptor. Thus, photodependent, irreversible blockade of α2-adrenoceptors by SKF 102229 was prevented by the concomitant presence of phentolamine or p-aminoclonidine but not by prazosin. Given its specificity and efficient blockade of the ligand binding site, SKF 102229 should prove useful for studies of the structure and function of α2-adrenoceptors.

UR - http://www.scopus.com/inward/record.url?scp=0022243443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022243443&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(85)90228-X

DO - 10.1016/0006-2952(85)90228-X

M3 - Article

C2 - 2864929

AN - SCOPUS:0022243443

VL - 34

SP - 3667

EP - 3672

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 20

ER -